Contact this trialFirst, we need to learn more about you.
Liposomal Doxorubicin + Carboplatin for Triple-negative Breast Cancer
Recruiting1 awardPhase 2
Newark, New Jersey
This trial will assess if combining 2 drugs is an effective & safe cancer treatment for early stage triple negative breast cancer patients, and explore if it can be used as a way to measure the effectiveness of the treatment.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service